End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.9 MYR | -1.55% | -5.47% | +31.94% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company has a good ESG score relative to its sector, according to Refinitiv.
Strengths
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With an expected P/E ratio at 29.04 and 26.98 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+31.94% | 1.76B | B+ | ||
-23.39% | 15.56B | B+ | ||
-2.70% | 11.65B | B | ||
+2.65% | 11.58B | B+ | ||
+4.08% | 10.06B | B+ | ||
+29.48% | 8.7B | B | ||
-10.76% | 7.16B | A- | ||
+8.05% | 6.85B | B- | ||
+3.94% | 5.71B | D | ||
+12.13% | 4.3B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- KPJ Stock
- Ratings KPJ Healthcare